Compounded medications require caution regarding safety criteria including licensing, clinician oversight, and sourcing checks
These changes include increased cardiovascular risk and risk of obstructive sleep apnea, declines in bone density and muscle mass, weight gain, poor sleep quality, changes in mood, and menofog, the difficulties with thinking and memory that are common during perimenopause
Regulatory push DCGIs Subject Expert Committee (SEC) has given Sun Pharma clearance to begin a Phase III clinical trial for its semaglutide tablets
Novo Nordisk appears to have settled with the generics before the IPRs were completed
Averaged over the treatment period, the difference in LS means for nasal itching was 0.27 points ( P = .016)